Nonparametric estimation and testing in a cure model.

Nonparametric generalized maximum likelihood product limit point estimators and confidence intervals are given for a cure model with random censorship. One-, two-, and K-sample likelihood ratio tests for inference on the cure rates are developed. In the two-sample case its power is compared to the power of several alternatives, including the log-rank and Gray and Tsiatis (1989, Biometrics 45, 899-904) tests. Implications for the use of the likelihood ratio test in a clinical trial designed to compare cure rates are discussed.

[1]  James H. Ware,et al.  On distribution-free tests for equality of survival distributions , 1977 .

[2]  S. S. Wilks.  The Likelihood Test of Independence in Contingency Tables , 1935 .

[3]  Vernon T. Farewell,et al.  Mixture models in survival analysis: Are they worth the risk? , 1986 .

[4]  Gregg E. Dinse,et al.  A mixture model for the regression analysis of competing risks data , 1985 .

[5]  Thomas Arbutiski.  A family of multiplicative survival models incorporating a long-term survivorship parameter c as a function of covariates , 1985 .

[6]  S. Wyard,et al.  THE NATURAL DURATION OF CANCER , 1925, Canadian Medical Association journal.

[7]  N. Breslow,et al.  A Large Sample Study of the Life Table and Product Limit Estimates Under Random Censorship , 1974 .

[8]  C Siegel,et al.  Onset and duration: Measurement and analysis , 1991, Clinical pharmacology and therapeutics.

[9]  S. S. Wilks.  The Large-Sample Distribution of the Likelihood Ratio for Testing Composite Hypotheses , 1938 .

[10]  E. Gehan.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[11]  Rupert G. Miller,et al.  Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.

[12]  Joel B. Greenhouse,et al.  A competing risks derivation of a mixture model for the analysis of survival data , 1984 .

[13]  A A Tsiatis,et al.  A linear rank test for use when the main interest is in differences in cure rates. , 1989, Biometrics.

[14]  A. V. Peterson.  Expressing the Kaplan-Meier estimator as a function of empirical subsurvival functions , 1977 .

[15]  A. Agresti,et al.  Categorical Data Analysis , 1991, International Encyclopedia of Statistical Science.

[16]  H. Sather,et al.  Determining the duration of comparative clinical trials while allowing for cure. , 1985, Journal of chronic diseases.

[17]  J Halpern,et al.  Designing clinical trials with arbitrary specification of survival functions and for the log rank or generalized Wilcoxon test. , 1987, Controlled clinical trials.

[18]  DavidR . Thomas,et al.  Confidence Interval Estimation of Survival Probabilities for Censored Data , 1975 .

[19]  H. Sather,et al.  A comparison of tests of the difference in the proportion of patients who are cured. , 1992, Biometrics.

[20]  M H Gail,et al.  Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. , 1981, Journal of chronic diseases.

[21]  J. Boag,et al.  Maximum Likelihood Estimates of the Proportion of Patients Cured by Cancer Therapy , 1949 .

[22]  K. Yamaguchi.  Accelerated Failure-Time Regression Models with a Regression Model of Surviving Fraction: An Application to the Analysis of “Permanent Employment” in Japan , 1992 .

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[24]  N. Breslow.  A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship , 1970 .

[25]  J Halpern,et al.  Cure rate models: power of the logrank and generalized Wilcoxon tests. , 1987, Statistics in medicine.

[26]  M S Pepe,et al.  Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data. , 1989, Biometrics.